New Directions in Cancer Treatment: UICC International Union Against Cancer
Editat de Ian T. Magrath Contribuţii de K.H. Antmanen Limba Engleză Paperback – 16 mar 1989
Preț: 386.03 lei
Preț vechi: 406.35 lei
-5% Nou
Puncte Express: 579
Preț estimativ în valută:
73.90€ • 76.82$ • 61.27£
73.90€ • 76.82$ • 61.27£
Carte tipărită la comandă
Livrare economică 06-20 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783540190639
ISBN-10: 3540190635
Pagini: 664
Ilustrații: XVIII, 631 p. 26 illus.
Dimensiuni: 170 x 244 x 35 mm
Greutate: 1.04 kg
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria UICC International Union Against Cancer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3540190635
Pagini: 664
Ilustrații: XVIII, 631 p. 26 illus.
Dimensiuni: 170 x 244 x 35 mm
Greutate: 1.04 kg
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria UICC International Union Against Cancer
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
1. New Directions in Cancer Treatment: An Overview.- Physical Approaches to Therapy.- 2. New Approaches in Radiation Therapy.- 3. Radiotherapy Treatment Planning: Past, Present, and Future.- 4. Hyperthermia as Cancer Therapy: Current Status and Future Prospects.- 5. Photodynamic Therapy.- Chemotherapy.- 6. Very High Dose Therapy in Lymphomas and Solid Tumors.- 7. Allogeneic Marrow Transplantation for Malignancy—Current Problems and Prospects for Improvement.- 8. Regional Therapies.- 9. Drug Resistance in Cancer.- 10. Multidrug Resistance in Tissue Culture and Human Tissues.- 11. Development of New Chemotherapeutic Agents.- 12. New Drug Trials.- 13. Drug Delivery to Brain Tumors.- Biological Approaches to Therapy.- 14. The Evaluation of Biological Response Modifiers for Cancer Therapy.- 15. Biologic Response Modifiers in Cancer Therapy.- 16. The Potential Value of Radiolabelled Monoclonal Antibodies in Cancer Therapy.- 17. Monoclonal Antibody Conjugates with Cytotoxic Agents for Cancer Therapy.- 18. Bone Marrow Purging.- 19. Future Prospects for the Treatment of Hormone-Responsive Tumors.- Potential Approaches.- 20. Tumor Invasion and Metastases: Biochemical Mechanisms.- 21. Prospects for the Development of Antineoplastic Therapy Based on Molecular Pathology.- 22. Differentiation of Malignant Cells as a Strategy for Cancer Treatment.- Therapeutic Trends in Specific Neoplasms.- 23. Malignant Brain Tumors.- 24. Head and Neck Cancer.- 25. Lung Cancer.- 26. Breast Cancer.- 27. Renal Cell Carcinoma.- 28. Carcinoma of the Pancreas.- 29. Hepatocellular Carcinoma.- 30. Esophageal Carcinoma.- 31. Gastric Cancer.- 32. Colon Cancer.- 33. Bladder Cancer.- 34. Prostate Cancer.- 35. Advanced Germ Cell Tumors.- 36. Ovarian Cancer.- 37. Trophoblastic Neoplasia.- 38. Malignant AdrenalTumors.- 39. Neuroendocrine Tumors.- 40. Soft Tissue Sarcomas in Adults.- 41. Melanoma.- 42. Basal Cell Carcinoma.- 43. Acute Lymphoblastic Leukemia.- 44. Acute Nonlymphoblastic Leukemia.- 45. The Chronic Leukemias.- 46. Hodgkin’s Disease.- 47. Plasma Cell Myeloma.- 48. Follicular Non-Hodgkin’s Lymphomas.- 49. Diffuse Aggressive Lymphomas in Adults.- 50. Childhood Non-Hodgkin’s Lymphomas.- 51. Osteosarcoma.- 52. Ewing’s Sarcoma.- 53. Soft Tissue Sarcomas in Childhood.- 54. Wilms’ Tumor.- 55. Neuroblastoma.- 56. Retinoblastoma.